Moreover, before CHEK2 c.1100delC was identified to be a moderate-risk BC susceptibility gene, it was actually a candidate gene for Li-Fraumeni syndrome [1, 2, 52, 53], which is caused by germline mutations in TP53 [54, 55]. The gene discussed is TP53; the disease is breast cancer.